Next 10 |
2024-07-05 13:07:29 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips One of many stock market indexes used to measure performance, the Russell 2000 is composed of 2,000 small-cap companies that make up the bottom two-thirds of the Russell 3000 index. The...
Aadi Bioscience to Participate in the Jefferies Healthcare Conference PR Newswire LOS ANGELES , May 29, 2024 /PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage precision oncology company focused on developing and commercializing therapi...
Aadi Bioscience Presents New Nonclinical Data Demonstrating Preferential Tumor Uptake of nab-Sirolimus at the American Society of Clinical Oncology (ASCO) Annual Meeting PR Newswire nab-Sirolimus demonstrated significantly greater intratumoral drug concentration, stronger inhi...
2024-05-08 12:58:03 ET Aadi Bioscience, Inc. (AADI) Q1 2024 Earnings Conference Call May 08, 2024, 8:30 AM ET Company Participants Dave Lennon - President and Chief Executive Officer Scott Giacobello - Chief Financial Officer, Investor Relations and Corporate Communi...
2024-05-08 08:04:39 ET More on Aadi Bioscience Seeking Alpha’s Quant Rating on Aadi Bioscience Historical earnings data for Aadi Bioscience Read the full article on Seeking Alpha For further details see: Aadi Bioscience GAAP EPS of -$0.68 misses by...
Aadi Bioscience Announces Financial Results for the First Quarter 2024 and Provides Corporate Update PR Newswire Fully enrolled registration-intended PRECISION1 trial; two-thirds interim analysis planned for Q3 2024 FYARRO® sales of $5.4 million for Q1...
Apartment Investment and Management Company (AIV) is expected to report for Q1 2024 Shopify Inc. Class A Subordinate (SHOP) is expected to report $0.08 for Q1 2024 Beyond Meat Inc. (BYND) is expected to report $-0.68 for Q1 2024 Instructure Holdings Inc. (INST) is expected to report $...
2024-05-07 14:25:42 ET More on Aadi Bioscience Aadi Bioscience, Inc. (AADI) Q4 2023 Earnings Call Transcript Aadi Bioscience Q4 2023 Earnings Preview Seeking Alpha’s Quant Rating on Aadi Bioscience Historical earnings data for Aadi Bioscience F...
Aadi Bioscience to Report First Quarter 2024 Results and Corporate Update PR Newswire Company to Host Conference Call and Webcast on May 8, 2024 LOS ANGELES , May 1, 2024 /PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage precis...
Aadi Bioscience to Present New Non-clinical Data Highlighting Combinability of nab-Sirolimus at the American Association for Cancer Research (AACR) Annual Meeting PR Newswire Data further support clinical exploration of nab-sirolimus in combination with endocrine therapy for h...
News, Short Squeeze, Breakout and More Instantly...
Aadi Bioscience to Participate in the Jefferies Healthcare Conference PR Newswire LOS ANGELES , May 29, 2024 /PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage precision oncology company focused on developing and commercializing therapi...
Aadi Bioscience Presents New Nonclinical Data Demonstrating Preferential Tumor Uptake of nab-Sirolimus at the American Society of Clinical Oncology (ASCO) Annual Meeting PR Newswire nab-Sirolimus demonstrated significantly greater intratumoral drug concentration, stronger inhi...